NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Wednesday that its third-quarter revenues increased 21 percent year over year driven by strong consumables growth.

The firm also said in a separate announcement Wednesday that it has filed litigation against NanoString Technologies alleging deceptive marketing practices in an advertising campaign for its nCounter gene expression assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.